(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) and the US ($600.)

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013
18:04

Meta Introduces Palm-Sized Device to Use Muse AI
19:04

Disney+ Price to Jump 13% to $21.49 Per Month
22:21